Skip to main content
. 2015 Mar 26;6(14):12234–12247. doi: 10.18632/oncotarget.3498

Appendix 1. IHC Thresholds.

Protein Threshold for Overexpression (Intensity and %expression in tumor)
AR ≥ 1+ and ≥ 10%
cKIT ≥ 2+ and ≥ 30%
cMET ≥ 2+ and ≥ 50%
EGFR 2+ and = 10% or 1+ and < 10%; current = H-score, < 200 or ≥ 200
ER ≥ 1+ and ≥ 10%
PR ≥ 1+ and ≥ 10%
HER2 ≥ 3+ and > 10%
PD-1 ≥ 1+ (TIL Count/High power field with 40x objective)
PD-L1 ≥ 2+ and ≥ 5%
PDGFRA ≥ 2+ and 30%
PGP ≥ 1+ and ≥ 10%
SPARC ≥ 2+ and ≥ 30%
TLE3 ≥ 2+ and ≥ 30%
TOPO1 ≥ 2+ and ≥ 30%
TOP2A ≥ 1+ and ≥ 10%
TUBB3 ≥ 2+ and ≥ 30%
Protein Threshold for Loss (Intensity and %expression in tumor)
ERCC1 < 2+ or ≤ 3+ and < 10% or = 2+ and < 50%
MGMT = 0+ or ≤ 35%
PTEN = 0+ or ≤ 50%
RRM1 < 2+ or < 50%